U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
VELTUZUMAB
INN   MART.   USAN   WHO-DD  
USAN   INN  
Official Name English
HA20
Preferred Name English
VELTUZUMAB [MART.]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HA20 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HA20 .KAPPA.-CHAIN, DIMER
Common Name English
veltuzumab [INN]
Common Name English
IMMU-106
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HA20 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HA20 .KAPPA.-CHAIN, DIMER
Common Name English
Veltuzumab [WHO-DD]
Common Name English
VELTUZUMAB [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 486915
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
FDA ORPHAN DRUG 454714
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
EU-Orphan Drug EU/3/09/713
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
FDA ORPHAN DRUG 261308
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
Code System Code Type Description
SMS_ID
100000168551
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
NCI_THESAURUS
C48406
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
USAN
SS-91
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
WIKIPEDIA
VELTUZUMAB
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
FDA UNII
BPD4DGQ314
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
CAS
728917-18-8
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
DRUG BANK
DB05656
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
ChEMBL
CHEMBL1743088
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
EVMPD
SUB182017
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
INN
8932
Created by admin on Mon Mar 31 20:33:18 GMT 2025 , Edited by admin on Mon Mar 31 20:33:18 GMT 2025
PRIMARY
ACTIVE MOIETY
VELTUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966